Urgent.News

What's breaking now, across hundreds of outlets.

Health & Medicine

Judge approves $7.25bn settlement for Roundup weedkiller cancer claims

A Missouri judge on Friday approved a $7.25bn (£5.5bn) settlement stemming from lawsuits alleging that Bayer’s weedkiller Roundup causes cancer. Judge Timothy Boyer said the settlement was “fair, reasonable, and adequate”. Bayer, the German bio-tech giant, had proposed paying the $7.25bn to definitively resolve a legal battle in the US. The nationwide settlement will be [...] The post Judge…

A Missouri judge has greenlit a $7.25bn (£5.5bn) settlement tied to lawsuits claiming Bayer's weedkiller Roundup leads to cancer. Judge Timothy Boyer deemed the settlement "fair, reasonable, and adequate". Bayer, the German biotech company, proposed the payment to neatly wrap up the legal dispute in the United States. The nationwide settlement will compensate Roundup users already diagnosed with non-Hodgkin lymphoma, as well as those yet to fall ill from its usage.

The company has already spent around $10bn settling other Roundup-related lawsuits. The payouts to participants span from $10,000 to $165,000, contingent on the frequency of usage, diagnosis timing, and the severity of the illness. Bayer will contribute to a fund annually for up to 21 years, potentially reaching $7.25bn. Some legal representatives contested the settlement size, claiming it was insufficient, yet the judge opted against delaying payouts to affected individuals.

Bayer maintains that its Roundup product does not cause cancer. This settlement follows the Supreme Court's ruling in June in favor of Bayer, which overturned a $1.25m settlement for a Missouri man who claimed Roundup and its component glyphosate caused his non-Hodgkin lymphoma. The court ruled 7-2, stating Bayer cannot be sued in state courts due to federal regulations that do not require a cancer warning label.

Bayer has faced thousands of claims in US state and federal courts from individuals alleging they developed cancer after using the product. Roundup was created by Monsanto in the 1970s. Its active ingredient, glyphosate, was labeled a probable human carcinogen by the International Agency for Research on Cancer, a division of the World Health Organization in 2015.

Bayer and other regulators, including the US Environmental Protection Agency, have refuted those findings. Nevertheless, the controversy has led the company through years of costly litigation in the US as juries in several states opt to award billions of dollars to Roundup users.

Rewritten by urgent.news; may contain errors — check the original.

Read the original at kahawatungu.com →

Report a problem with this story

More in Health & Medicine

More from Saturday 21 November →